Johnson & Johnson

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 ''Fortune'' 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the ''Forbes'' Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.

Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. Over time, it developed some of the most recognizable healthcare products, including the first commercial first aid kit, maternity kits, baby powder, Band-Aids, Tylenol, and disposable contact lenses, establishing itself as a leading provider of medical products and consumer healthcare solutions.

Johnson & Johnson expanded globally through acquisitions of major pharmaceutical and medical device companies such as Janssen, Ethicon, McNeil, and Actelion. It developed breakthrough treatments including RhoGAM for Rh incompatibility, HIV therapies, and the antidepressant Spravato (esketamine). The company has played major roles during public health crises from the 1918 influenza pandemic to COVID-19.

Johnson & Johnson has faced significant legal and ethical challenges, including the Tylenol murders, hip implant failures, Risperdal marketing claims, transvaginal mesh lawsuits, and talc-related cancer cases. In 2023, it spun off its consumer health division as the publicly traded Kenvue, focusing its business on Innovative Medicine and MedTech. By 2025, the company reported nearly $89 billion in revenue and continued large-scale acquisitions. Provided by Wikipedia